EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L	Lung Adenocarcinoma	EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L	Lung Adenocarcinoma	camrelizumab Sensitive: C4 – Case Studies camrelizumab Sensitive : C4	camrelizumab Sensitive: C4 – Case Studies camrelizumab Sensitive : C4
EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L	Lung Adenocarcinoma	EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L	Lung Adenocarcinoma	sintilimab Sensitive: C4 – Case Studies sintilimab Sensitive : C4	sintilimab Sensitive: C4 – Case Studies sintilimab Sensitive : C4

EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L

Associations